Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival. - Coltelli L; Orlandi P; Finale C; Musettini G; Masini LC; Scalese M; Soria G; Sartori E; Nodari Y; Arrighi G; Bandini A; Banchi M; et al. (Oncology research, 2026)